Rheumatoid Arthritis Drug Getting Mixed Reviews as Coronavirus Treatment

<p>We are getting some mixed results on a rheumatoid arthritis drug that was showing some promise in treating patients with COVID-19. In a large study, the drug showed promise in reducing deaths of people who were admitted to the ICU. In some smaller studies, the drug showed no benefit. Still the drug has been added to a growing list of possible therapeutics. Karen Weintraub, health reporter at USA Today, joins us for more.</p><p> </p> Learn more about your ad-choices at <a href="https://www.iheartpodcastnetwork.com">https://www.iheartpodcastnetwork.com</a><p>See <a href="https://omnystudio.com/listener">omnystudio.com/listener</a> for privacy information.</p>